A study by den Broeder et al. revealed that TNF-α neutralization reduced the YKL-40 levels in RA patients, supporting the role of TNF-α in the regulation of YKL-40 levels [38]. This evidence concerns the gene CHI3L1 and rheumatoid arthritis.